Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Infections and Infectious Diseases
 Disease Category: Human Papilloma Virus (HPV)
Location: United States, OR

Trial Information

Therapeutic Human Papilloma Virus (HPV) Vaccine

Patient Inclusion Criteria

  • Female subjects age 18-55 years
  • Histologically confirmed HPV-16 or HPV-18-associated CIN 2/3 or CIN 3 from a biopsy less than 8 weeks prior to Vaccination/EP #1 with no evidence of invasive cancer in any specimen;
  • Women of child-bearing potential agree to remain sexually abstinent, use two medically effective methods of contraception (oral contraception, barrier methods, spermicide, etc), or have a partner who is sterile (i.e., vasectomy) through 36 weeks (9 months)

Patient Exclusion Criteria

  • History of previous therapeutic HPV vaccination
  • Administration of any licensed vaccine within 2 weeks of enrollment (4 weeks for measles vaccine)

Toni Myers, RN
Clinical Trials of America, Inc
10 Coburg Rd., Suite 200
Eugene, OR 97401
Phone: 541-349-0523
Email: tonim@ctofa.com

View Map

Research Center Information: Clinical Trials of America, Inc

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.